A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Figure 2.The expression levels of Gefitinib target genes in LUAD tissues. (A) High expression; (B) Low expression. Abbreviations: LUAD: Lung adenocarcinoma; T: LUAD tissues; N: normal tissues.